Market
Iterum Therapeutics Plc [ITRM] is -19.80% lower this YTD. Is it still time to buy?
Iterum Therapeutics Plc [NASDAQ: ITRM] closed the trading session at $1.58. The company report on January 30, 2024 at 7:00 AM that Iterum Therapeutics Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections. Phase 3
